Bevacizumab-IRDye 800CW
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bevacizumab-IRDye 800CW, covering 2020-01-28 to 2020-01-28. Get the full timeline:
Most recent: Clinical Trial Update: FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW [Phase 1, Phase 2]